Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 1
2015 2
2016 1
2017 1
2018 1
2019 1
2020 2
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Reactive perforating collagenosis.
Arora S, Malik A, Balki A. Arora S, et al. Among authors: balki a. Indian Dermatol Online J. 2016 Mar-Apr;7(2):139-40. doi: 10.4103/2229-5178.178084. Indian Dermatol Online J. 2016. PMID: 27057507 Free PMC article. No abstract available.
Evaluation of the Safety and Efficacy of Favipiravir in Adult Indian Patients with Mild-to-Moderate COVID-19 in a Real-World Setting.
Reddy PK, Patil S, Khobragade A, Balki A, Raj A, Kalikar M, Reddy R, Shinde R, Cr J, Mutha A, Boyilla N, Rajadhyaksha GC, Karnik N, Bhagat S, Pendse A, Dhage P, Wu W, Rangwala S, Barkate H. Reddy PK, et al. Among authors: balki a. Int J Gen Med. 2022 May 3;15:4551-4563. doi: 10.2147/IJGM.S349241. eCollection 2022. Int J Gen Med. 2022. PMID: 35535140 Free PMC article. Clinical Trial.
Annular elastolytic giant cell granuloma: A report of 10 cases.
Arora S, Malik A, Patil C, Balki A. Arora S, et al. Among authors: balki a. Indian Dermatol Online J. 2015 Dec;6(Suppl 1):S17-20. doi: 10.4103/2229-5178.171055. Indian Dermatol Online J. 2015. PMID: 26904442 Free PMC article.
Efficacy and safety of single-inhaler triple therapy of glycopyrronium, formoterol and fluticasone in patients with COPD: a double-blind, randomised controlled trial.
Salvi S, Balki A, Krishnamurthy S, Panchal S, Patil S, Kodgule R, Khandagale H, Pendse A, Wu W, Rangwala S, Tandon M, Barkate H. Salvi S, et al. Among authors: balki a. ERJ Open Res. 2021 Jul 26;7(3):00255-2021. doi: 10.1183/23120541.00255-2021. eCollection 2021 Jul. ERJ Open Res. 2021. PMID: 34322547 Free PMC article.
Tiotropium Respimat inhaler and the risk of death in COPD.
Wise RA, Anzueto A, Cotton D, Dahl R, Devins T, Disse B, Dusser D, Joseph E, Kattenbeck S, Koenen-Bergmann M, Pledger G, Calverley P; TIOSPIR Investigators. Wise RA, et al. N Engl J Med. 2013 Oct 17;369(16):1491-501. doi: 10.1056/NEJMoa1303342. Epub 2013 Aug 30. N Engl J Med. 2013. PMID: 23992515 Free article. Clinical Trial.
Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to-severe COPD.
Salvi S, Jain MK, Krishnamurthy S, Balki A, Kodgule R, Tandon M, Bhagat S, Panchal S, Khatri N, Wu W, Pendse A, Patil S, Barkate H. Salvi S, et al. Among authors: balki a. Lung India. 2022 Nov-Dec;39(6):517-524. doi: 10.4103/lungindia.lungindia_136_22. Lung India. 2022. PMID: 36629230 Free PMC article.
Real-world evaluation of the clinical safety and efficacy of fluticasone/formoterol FDC via the Revolizer® in patients with persistent asthma in India.
Ghoshal A, Waghray P, Dsouza G, Saluja M, Agarwal M, Goyal A, Limaye S, Balki A, Bhatnagar S, Jain M, Tikkiwal S, Vaidya A, Lopez M, Hegde R, Gogtay J. Ghoshal A, et al. Among authors: balki a. Pulm Pharmacol Ther. 2020 Feb;60:101869. doi: 10.1016/j.pupt.2019.101869. Epub 2019 Nov 30. Pulm Pharmacol Ther. 2020. PMID: 31794836 Clinical Trial.
12 results